Abstract
Seven antimuscarinic compounds, used mostly for the treatment of extrapyramidal problems, were tested in vitro in radioligand binding assays for evidence of selectivity for two different pharmacological subtypes of the human muscarinic receptor, M1, a predominant form in brain, and M2, a predominant form in heart. Although biperiden, scopolamine, procyclidine, and benztropine showed significant selectivity in the in vitro assays, it is likely that in clinical practice biperiden would be the drug of choice to avoid any antimuscarinic effects on the heart.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anonymous (1989) Physician's desk reference, 43rd edn. Medical Economics, Oradell, New Jersey
Belmaker RH, Schreiber G, Avissar S (1988) Clinical implications of receptor selectivity of anticholinergic drugs. Soc Biol Psych, forty-third annual meeting, Abstracts, p. 103
Black JL, Richelson E, Richardson JW (1985) Antipsychotic agents: a clinical update. Mayo Clin Proc 60:777–789
Bonner TI (1989) New subtypes of muscarinic acetylcholine receptors. TIPS [Suppl] Dec: 11–15
Garvey JM, Rossor M, Iversen LL (1984) Evidence for multiple muscarinic receptor subtypes in human brain. J Neurochem 43:299–302
Ghose K (1985) The pharmacological basis of drug therapy of parkinsonism. Drugs of Today 21:463–471
Giachetti A, Giraldo E, Ladinsky H, Montagna E (1986a) Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol 89:83–90
Giachetti A, Micheletti R, Montagna E (1986b) Cardioselective profile of AF-DX116, a muscarinic M2-receptor antagonist. Life Sci 38:1663–1672
Hammer R, Giachetti A (1982) Muscarinic receptor subtypes: M1 and M2. Biochemical and functional characterization. Life Sci 31:2991–2998
Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–92
Lazareno S, Roberts FF (1989) Functional and binding studies with muscarinic M2-subtype selective antagonists. Br J Pharmacol 98:309–317
Lin S-C, Olson KC, Richelson E (1986) Studies on muscarinic binding sites in human brain identified with [3H]pirenzepine. J Neurochem 46:274–279
Luber-Narod J, Potter LT (1983) Selectivity of drugs for M1 and M2 muscarinic receptors. Soc Neurosci 9:682
McKinney M, Anderson D, Forray C, El-Fakahany EE (1989) Characterization of striatal M2 muscarinic receptor mediating inhibition of cyclic AMP using selective antagonists: a comparison with the brainstem M2 receptor. J Pharmacol Exp Ther 250:565–572
Munson PJ, Rodbard D (1980) LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220–239
Syvalahti EKG, Lauren L, Markkanen J (1987) Interaction of psychotropic drugs with brain muscarinic cholinoceptors: similarities of biperiden with pirenzepine in receptor binding properties. Pharmacol Toxicol 60:66–69
Syvalahti EKG, Kunelius R, Lauren L (1988) Effects of antiparkinsonian drugs on muscarinic receptor binding in rat brain, heart and lung. Pharmacol Toxicol 62:90–94
Tien XY, Wallace LJ (1985) Trihexyphenidyl — further evidence for muscarinic receptor subclassification. Biochem Pharmacol 34:588–590
Watson M, Yamamura HI, Roeske WR (1983) A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci 32:3001–3011
Watson M, Roeske WR, Johnson PC (1984) [3H]pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia. Brain Res 290:179–182
Yamamura HI, Snyder SH (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725–1729
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Larson, E.W., Pfenning, M.A. & Richelson, E. Selectivity of antimuscarinic compounds for muscarinic receptors of human brain and heart. Psychopharmacology 103, 162–165 (1991). https://doi.org/10.1007/BF02244197
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02244197